Researchers
Dragoj, Miodrag
Results 21-40 of 110
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2024 | Functional Diagnostics in Personalized Therapy for Non-Small Cell Lung Carcinoma | Podolski-Renić, Ana | Conference Paper | Mp. category will be shown later |
| 2024 | Optimizing Treatment Response in Lung Squamous Cell Carcinoma by Cell-Based Functional Sensitivity Screening | Podolski-Renić, Ana | Article | Mp. category will be shown later |
| 2024 | Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors | Dinić, Jelena | Article | 21M21 |
| 2024 | Functional diagnostics in non-small cell lung carcinoma - the potential for personalized approach | Lupšić, Ema | Conference Paper | Mp. category will be shown later |
| 2024 | Adaptable alginate-based microfibers for 3D in vitro cultures of cancer cells: an anticancer drug testing model![]() | Petrović, Jelena | Conference Paper | Mp. category will be shown later |
| 2024 | Biomimetic tumor engineering to enhance drug discovery - BioengineeredTumor![]() | Obradović, Bojana | Conference Paper | Mp. category will be shown later |
| 2023 | Long-term three-dimensional glioblastoma cell culture model for drug response studies | Dragoj, Miodrag | Conference Paper | Mp. category will be shown later |
| 2023 | Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts![]() | Jovanović Stojanov, Sofija | Conference Paper | Mp. category will be shown later |
| 2023 | Alginate Microfibers with Immobilized Cancer Cells as a 3D Cancer Model for Anticancer Drug Testing![]() | Petrović, Jelena | Conference Paper | Mp. category will be shown later |
| 2023 | Advantages and challenges in development of perfusion-based 3D cell cultures![]() | Obradović, Bojana | Conference Paper | Mp. category will be shown later |
| 2023 | New anti-glioblastoma strategy with natural compounds sclareol and doxorubicin![]() | Stepanović, Ana | Conference Paper | Mp. category will be shown later |
| 2023 | Novel functional immunoassay for identification of multidrug resistance markers in non-small cell lung carcinoma patient-derived cells![]() | Stepanović, Ana | Conference Paper | Mp. category will be shown later |
| 2023 | High-throughput screening of multidrug-resistance markers in non-small cell lung carcinoma patient-derived cells - contribution to personalized treatment | Jovanović Stojanov, Sofija | Conference Paper | Mp. category will be shown later |
| 2023 | Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells | Dinić, Jelena | Article | 21M21 |
| 2023 | Functional diagnostics and ex-vivo screening of erlotinib and nintedanib in non-small cell lung carcinoma: Implications for multidrug resistance and personalized therapy | Dinić, Jelena | Conference Paper | Mp. category will be shown later |
| 2022 | A platform for reliable preclinical testing of anticancer drugs![]() | Stojkovska, Jasmina | Conference Paper | Mp. category will be shown later |
| 2022 | Development of 3D cancer cell culture models for anti-tumor drug testing![]() | Obradović, Bojana | Conference Paper | Mp. category will be shown later |
| 2022 | Decreased TSPAN14 Expression Contributes to NSCLC Progression | Jovanović, Mirna | Article | 21M21 |
| 2022 | Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells![]() | Divac Rankov, Aleksandra | Article | 21aM21a |
| 2022 | Development of a 3D Microenvironment for Engineering of Glioblastoma Brain Tumor![]() | Stojkovska, Jasmina | Conference Paper | Mp. category will be shown later |
